Download Now

This week's Fierce Biotech is brought to you by IQVIA Holdings.

Trouble viewing? Click here.


The ROI of Patient-Defined Recruitment


Increased engagement, higher referral to randomization rate and reduced timelines


It has never been more important to recruit the right participants for your clinical trials, but that’s only possible with a well-defined patient-first recruitment strategy.

IQVIA’s Direct-to-Patient recruitment solution has helped over 34 sponsors across 50+ countries implement the right recruitment strategy to find trial participants in the broader community – leading to fully optimized trials.

Download the whitepaper “Patient-Defined Recruitment: The Movement Advanced by the Pandemic” to learn how a combination of AI/ML and patient insights deliver dynamic patient models that redefine patient engagement strategies and improve ROI for a multitude of studies including Central Nervous System (CNS), Cardiovascular and Infectious Disease and Vaccines (IDV).





Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.


You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017